Skip to main content
Recall Canary
Metoprolol Succinate Extended-Release Tablets
← Back to all recalls
DRUG RECALLMODERATE

Metoprolol Succinate Extended-Release Tablets

Teva is recalling Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking your medication without consulting a doctor.

Posted
Updated
Recall No.
D-0357-2026
Agency
Firm
Teva Pharmaceuticals USA, Inc
Recall ID
98348
Status
ONGOING

Why it was recalled

Failed Dissolution Specifications

How to identify it

Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11

Where it was sold

Distributed in US.

Other recent recalls from Teva Pharmaceuticals USA, Inc

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification